Cite
Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data.
MLA
Merritt, Kate, et al. “Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-Analysis of Individual Participant-Level Data.” JAMA Psychiatry, vol. 78, no. 6, June 2021, pp. 667–81. EBSCOhost, https://doi.org/10.1001/jamapsychiatry.2021.0380.
APA
Merritt, K., McGuire, P. K., Egerton, A., Aleman, A., Block, W., Bloemen, O. J. N., Borgan, F., Bustillo, J. R., Capizzano, A. A., Coughlin, J. M., De la Fuente-Sandoval, C., Demjaha, A., Dempster, K., Do, K. Q., Du, F., Falkai, P., Galinska-Skok, B., Gallinat, J., Gasparovic, C., … Yamasue, H. (2021). Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data. JAMA Psychiatry, 78(6), 667–681. https://doi.org/10.1001/jamapsychiatry.2021.0380
Chicago
Merritt, Kate, Philip K McGuire, Alice Egerton, André Aleman, Wolfgang Block, Oswald J N Bloemen, Faith Borgan, et al. 2021. “Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-Analysis of Individual Participant-Level Data.” JAMA Psychiatry 78 (6): 667–81. doi:10.1001/jamapsychiatry.2021.0380.